Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2023-01-03+8,000→ 15,419 total
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter.